| A novel cisplatin mediated apoptosis pathway is associated with acid sphingomyelinase and FAS proapoptotic protein activation in ovarian cancer L Maurmann, L Belkacemi, NR Adams, PM Majmudar, S Moghaddas, ... Apoptosis 20, 960-974, 2015 | 46 | 2015 |
| Phosphaplatins, next generation platinum antitumor agents: a paradigm shift in designing and defining molecular targets S Moghaddas, P Majmudar, R Marin, H Dezvareh, C Qi, E Soans, ... Inorganica Chimica Acta 393, 173-181, 2012 | 27 | 2012 |
| Absence of activation of DNA repair genes and excellent efficacy of phosphaplatins against human ovarian cancers: implications to treat resistant cancers RN Bose, S Moghaddas, L Belkacemi, S Tripathi, NR Adams, P Majmudar, ... Journal of Medicinal Chemistry 58 (21), 8387-8401, 2015 | 25 | 2015 |
| Investigating molecular targets of phosphaplatins: a class of novel non-DNA-binding platinum anticancer agents in the treatment of ovarian cancer PM Majmudar Ohio University, 2011 | 4 | 2011 |
| Superior Efficacy of Phosphoplatins: Novel Non‐DNA‐Binding Platinum Drugs for Human Ovarian Cancer S Moghaddas, P Majmudar, RN Bose The FASEB Journal 24, 527.2-527.2, 2010 | 2 | 2010 |
| Construction of Genomic Regulatory Encyclopedias: Strategies and Case Studies J Lichtenberg, M Alam, T Bitterman, F Drews, K Ecker, L Elnitski, S Evans, ... 2009 Ohio Collaborative Conference on Bioinformatics, 65-70, 2009 | | 2009 |
